AdaptHealth Corp. (NASDAQ:AHCO) Shares Bought by Sei Investments Co.

Sei Investments Co. increased its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 8.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 366,246 shares of the company's stock after purchasing an additional 28,633 shares during the quarter. Sei Investments Co. owned 0.27% of AdaptHealth worth $3,487,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Assetmark Inc. acquired a new stake in shares of AdaptHealth in the fourth quarter worth $28,000. Blue Trust Inc. boosted its position in AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after purchasing an additional 1,115 shares during the period. Quarry LP increased its holdings in AdaptHealth by 4,596.9% in the 3rd quarter. Quarry LP now owns 5,965 shares of the company's stock valued at $67,000 after purchasing an additional 5,838 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its position in AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock valued at $121,000 after purchasing an additional 1,690 shares during the period. Finally, LRI Investments LLC lifted its stake in shares of AdaptHealth by 32.0% during the third quarter. LRI Investments LLC now owns 15,331 shares of the company's stock worth $172,000 after purchasing an additional 3,713 shares in the last quarter. Hedge funds and other institutional investors own 82.67% of the company's stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on AHCO. Royal Bank of Canada increased their target price on AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Robert W. Baird increased their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Truist Financial upped their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. UBS Group dropped their price target on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research note on Thursday, February 13th. Finally, Canaccord Genuity Group upped their price objective on shares of AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $13.80.

AdaptHealth Stock Down 5.9 %

Shares of AHCO stock traded down $0.56 during mid-day trading on Tuesday, reaching $9.00. 1,615,430 shares of the company were exchanged, compared to its average volume of 1,202,824. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The business's 50 day simple moving average is $9.95 and its 200 day simple moving average is $10.10. The company has a market capitalization of $1.21 billion, a P/E ratio of -5.45, a P/E/G ratio of 1.08 and a beta of 1.44. AdaptHealth Corp. has a fifty-two week low of $8.35 and a fifty-two week high of $11.90.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.